Found 10 results
Author Title [ Type(Desc)] Year
Filters: Author is Depner, Christopher M  [Clear All Filters]
Journal Article
C. M. Depner, Philbrick, K. A., and Jump, D. B., Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis., J Nutr, vol. 143, no. 3, pp. 315-23, 2013.
C. M. Depner, Philbrick, K. A., and Jump, D. B., Docosahexaenoic Acid Attenuates Hepatic Inflammation, Oxidative Stress, and Fibrosis without Decreasing Hepatosteatosis in a Ldlr-/- Mouse Model of Western Diet-Induced Nonalcoholic Steatohepatitis., The Journal of nutrition, 2013.
K. A. Lytle, Depner, C. M., Wong, C. P., and Jump, D. B., Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway., J Lipid Res, vol. 56, no. 10, pp. 1936-46, 2015.
D. B. Jump, Tripathy, S., and Depner, C. M., Fatty acid-regulated transcription factors in the liver., Annu Rev Nutr, vol. 33, pp. 249-69, 2013.
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice., Proc Nutr Soc, vol. 75, no. 1, pp. 1-9, 2016.
C. M. Depner, Torres-Gonzalez, M., Tripathy, S., Milne, G., and Jump, D. B., Menhaden oil decreases high-fat diet-induced markers of hepatic damage, steatosis, inflammation, and fibrosis in obese Ldlr-/- mice., The Journal of nutrition, vol. 142, no. 8, pp. 1495-503, 2012.
C. M. Depner, Traber, M., Bobe, G., Kensicki, E., Bohren, K. M., Milne, G., and Jump, D. B., A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice., PLoS One, vol. 8, no. 12, p. e83756, 2013.
D. B. Jump, Depner, C. M., and Tripathy, S., Omega-3 fatty acid supplementation and cardiovascular disease., Journal of lipid research, vol. 53, no. 12, pp. 2525-45, 2012.
D. B. Jump, Lytle, K. A., Depner, C. M., and Tripathy, S., Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease., Pharmacol Ther, vol. 181, pp. 108-125, 2018.
D. B. Jump, Depner, C. M., Tripathy, S., and Lytle, K. A., Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer., Advances in nutrition (Bethesda, Md.), vol. 6, no. 6, pp. 694-702, 2015.